At a glance
ClinicalIndex Comparison RecordN/ACompleted· 318 enrolled
Drug / intervention
Not specified
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.
Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.
Tofacitinib Use in Rituximab-Experienced RA Patients
In Brief
An observational study for Arthritis, Rheumatoid. Completed, enrolled 318 participants across 1 site.
Detailed Summary
This study is to characterize the use of tofacitinib after use of rituximab in patients with Rheumatoid Arthritis in a real-world setting.
Study Details
Study Typeobservational
Allocation--
Masking--
Primary Purpose--
ConditionsArthritis, Rheumatoid
CountriesMorocco
Collaborators--
Timeline
N/ACompletedFinished
2023202420252026
First PostedAug 2022
Enrollment StartNov 2022
Primary CompletionDec 2022
TodayJul 2026
First PostedAug 4, 2022
Enrollment StartNov 14, 2022
Primary CompletionDec 23, 2022
TodayJul 2, 2026
Enrollment to primary: 1 monthPosted 3.9 years ago